RazorMetrics launching new blog

Share This Post

RazorMetrics is kicking off our new blog with a series called, “The Unsung Heroes of COVID, Interviews with HR Professionals”

We chose HR because there is a conspicuous absence of news reports about the people who are managing the work lives of others, the stress of layoffs and furloughs, helping employees get up and running with remote home offices while managing kids, or facility safety for those who must work onsite. We will be speaking with those who have a firsthand account on the front lines of human resources during a global disaster.

The blog will be featured on our website and will be posted on our social media sites (Twitter and LinkedIn). We hope you enjoy the series.

Read Part 1 HR The Unsung Heroes of COVID 

photo credit

More To Explore

Article

The Intersection of Drug Pricing Reforms and HealthTech Solutions

In an era where data is king, HealthTech companies are successfully driving effective drug cost-control strategies by leveraging analytics, demographic statistics, and care team insights. Since Congress enacted the HITECH Act, which offered financial incentives to health facilities to adopt Electronic Health Records (EHRs), health information entered the digital age. The wealth of health data combined with new Artificial Intelligence (AI) improvements has dramatically increased the computing capacity to process and analyze mountainous volumes of electronic patient data and drug price information.

Article

Innovative Solutions to the U.S. Drug Shortage Crisis: The Role of HealthTech 

Generic drug shortages are becoming a chronic condition in the United States. Shortages lead to a domino effect across the healthcare landscape because the lowest-cost medication is not readily accessible. Last week, the Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) issued a Request for Information to Group Purchasing Organizations (GPOs) and drug wholesalers to investigate how competition, contracting, and regulatory policies impact generic drug availability. Missing from the discussion is how HealthTech companies could manage the gaps.

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.